466 related articles for article (PubMed ID: 25520185)
1. Insights into the molecular basis of the NOD2 signalling pathway.
Boyle JP; Parkhouse R; Monie TP
Open Biol; 2014 Dec; 4(12):. PubMed ID: 25520185
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
[TBL] [Abstract][Full Text] [Related]
3. Blau syndrome revisited.
Rose CD; Martin TM; Wouters CH
Curr Opin Rheumatol; 2011 Sep; 23(5):411-8. PubMed ID: 21788900
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
5. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Le Bourhis L; Benko S; Girardin SE
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
7. Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.
Parkhouse R; Boyle JP; Monie TP
FEBS Lett; 2014 Sep; 588(18):3382-9. PubMed ID: 25093298
[TBL] [Abstract][Full Text] [Related]
8. NOD1 and NOD2 in inflammation, immunity and disease.
Mukherjee T; Hovingh ES; Foerster EG; Abdel-Nour M; Philpott DJ; Girardin SE
Arch Biochem Biophys; 2019 Jul; 670():69-81. PubMed ID: 30578751
[TBL] [Abstract][Full Text] [Related]
9. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
Nakano M; Kambe N
Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
[TBL] [Abstract][Full Text] [Related]
10. The role of NOD1 and NOD2 in host defense against chlamydial infection.
Zou Y; Lei W; He Z; Li Z
FEMS Microbiol Lett; 2016 Sep; 363(17):. PubMed ID: 27421958
[TBL] [Abstract][Full Text] [Related]
11. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
12. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
Philpott DJ; Viala J
Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of Arabinosylated lipoarabinomannan restrict the progression of visceral leishmaniasis through NOD2 inflammatory pathway: Functional regulation of T cell subsets.
Jawed JJ; Banerjee S; Bandyopadhyay S; Parveen S; Chowdhury BP; Saini P; Majumdar S
Biomed Pharmacother; 2018 Oct; 106():724-732. PubMed ID: 29990864
[TBL] [Abstract][Full Text] [Related]
14. NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice.
Rosenzweig HL; Galster K; Vance EE; Ensign-Lewis J; Nunez G; Davey MP; Rosenbaum JT
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4106-12. PubMed ID: 21296813
[TBL] [Abstract][Full Text] [Related]
15. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Pashenkov MV; Dagil YA; Pinegin BV
Int Immunopharmacol; 2018 Jan; 54():385-400. PubMed ID: 29207344
[TBL] [Abstract][Full Text] [Related]
16. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
17. NOD1 and NOD2: signaling, host defense, and inflammatory disease.
Caruso R; Warner N; Inohara N; Núñez G
Immunity; 2014 Dec; 41(6):898-908. PubMed ID: 25526305
[TBL] [Abstract][Full Text] [Related]
18. The different roles of innate immune receptors in inflammation and carcinogenesis between races.
Yamaguchi N; Suzuki Y; Mahbub MH; Takahashi H; Hase R; Ishimaru Y; Sunagawa H; Watanabe R; Eishi Y; Tanabe T
Environ Health Prev Med; 2017 Oct; 22(1):70. PubMed ID: 29165176
[TBL] [Abstract][Full Text] [Related]
19. Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands.
Magalhaes JG; Lee J; Geddes K; Rubino S; Philpott DJ; Girardin SE
Eur J Immunol; 2011 May; 41(5):1445-55. PubMed ID: 21469090
[TBL] [Abstract][Full Text] [Related]
20. Blau syndrome, the prototypic auto-inflammatory granulomatous disease.
Wouters CH; Maes A; Foley KP; Bertin J; Rose CD
Pediatr Rheumatol Online J; 2014; 12():33. PubMed ID: 25136265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
